Loading your page…
Loading your page…
Choose a research family to review the highest-velocity compounds in that class. Each hub stays synced with the 10,000-compound registry.
55518 dossiers
View familyFDA-approved therapeutic agents across diverse pharmacological categories.
184 dossiers
View familyAntithyroid agents for hyperthyroidism and thyroid storm.
37 dossiers
View familyCompounds classified in the Insulin family.
666 dossiers
View familyMineral supplements for potassium, magnesium, and electrolyte balance restoration.
1147 dossiers
View familyAntimicrobial agents targeting bacterial infections across respiratory, systemic, and localized sites.
240 dossiers
View familyGlucocorticoid anti-inflammatory agents for autoimmune, allergic, and inflammatory conditions.
28 dossiers
View familyMood-elevating agents modulating monoamine neurotransmitter systems.
698 dossiers
View familyEssential micronutrients for metabolic function and deficiency prevention.
4 dossiers
View familyCompounds classified in the Prodrug family.
104 dossiers
View familyAzole and echinocandin antifungals for systemic and localized fungal infections.
124 dossiers
View familyLocal and general anesthetics for surgical procedures and pain management.
47 dossiers
View familyProton pump inhibitors reducing gastric acid for GERD and ulcer treatment.
147 dossiers
View familyNon-steroidal anti-inflammatory drugs blocking cyclooxygenase for pain and inflammation control.
18 dossiers
View familyCompounds classified in the Psychedelic family.
3 dossiers
View familyCompounds classified in the Entactogen family.
182 dossiers
View familyEndocrine modulators including estrogens, androgens, and pituitary hormones.
39 dossiers
View familyH1 receptor antagonists for allergic rhinitis, urticaria, and motion sickness.
8 dossiers
View familyCompounds classified in the Amino Acid family.
65 dossiers
View familyAgents inhibiting viral replication for HIV, hepatitis, influenza, and herpes infections.
109 dossiers
View familyDopamine and serotonin receptor antagonists for schizophrenia and bipolar disorder management.
51 dossiers
View familyCytotoxic agents targeting rapidly dividing cells for cancer treatment.
94 dossiers
View familySmall molecule tyrosine kinase blockers for targeted cancer therapy and inflammatory conditions.
12 dossiers
View familyCompounds classified in the SARM family.
13 dossiers
View familyCompounds classified in the Superfood family.
1 dossiers
View familyCompounds classified in the Alcohol Treatment family.
201 dossiers
View familyNutritional supplements including minerals, amino acids, and metabolic cofactors.
3 dossiers
View familyCysteinyl leukotriene receptor blockers for asthma and allergies.
77 dossiers
View familyBeta-2 agonists and anticholinergics for asthma and COPD airway management.
115 dossiers
View familyAnti-epileptic compounds stabilizing neuronal membranes and modulating ion channels.
27 dossiers
View familyCognitive enhancers modulating acetylcholine, glutamate, and neurotrophic pathways.
16 dossiers
View familyOsmotic and stimulant agents for constipation and bowel preparation.
119 dossiers
View familyEngineered antibodies targeting specific antigens for cancer, autoimmune, and inflammatory diseases.
4 dossiers
View familyClot-dissolving agents for acute stroke, myocardial infarction, and pulmonary embolism intervention.
94 dossiers
View familyCNS depressants binding opioid receptors for acute pain management and anesthesia protocols.
23 dossiers
View familyL-type calcium channel antagonists for hypertension and angina control.
14 dossiers
View familyTargeted therapies and immunomodulators engineered for precision cancer treatment and tumor suppression.
13 dossiers
View familyPhosphodiesterase-5 blockers increasing cGMP for erectile dysfunction and pulmonary hypertension.
2 dossiers
View familyCompounds classified in the ADHD Stimulant family.
26 dossiers
View familyCompounds classified in the Anabolic Steroid family.
22 dossiers
View familyAdrenergic receptor blockers for hypertension, arrhythmia, and heart failure.
17 dossiers
View familyIncretin mimetics engineered for glycemic control, appetite suppression, and cardiometabolic optimization.
84 dossiers
View familyGlucose-regulating compounds for type 1 and type 2 diabetes metabolic stabilization.
2 dossiers
View familyCompounds classified in the Eugeroic family.
31 dossiers
View familyCNS activators enhancing dopamine and norepinephrine for focus, alertness, and ADHD management.
26 dossiers
View familyCalcineurin and mTOR inhibitors for transplant rejection and autoimmune diseases.
101 dossiers
View familyHormonal agents for pregnancy prevention and menstrual cycle regulation.
3 dossiers
View familyCompounds classified in the Decongestant family.
18 dossiers
View familyBlood thinning agents preventing clot formation for cardiovascular and thrombotic risk management.
9 dossiers
View familyPlatelet aggregation inhibitors for stroke and cardiovascular prevention.
100 dossiers
View familyRenal agents promoting sodium and water excretion for hypertension and edema.
12 dossiers
View familyAnti-nausea agents blocking 5-HT3 and dopamine receptors for chemotherapy-induced vomiting.
10 dossiers
View familyCompounds classified in the Antioxidant family.
48 dossiers
View familyGABA-A positive allosteric modulators for anxiety, seizure, and sleep disorders.
20 dossiers
View familyAngiotensin-converting enzyme blockers for hypertension and heart failure management.
28 dossiers
View familyHMG-CoA reductase inhibitors lowering LDL cholesterol for cardiovascular risk reduction.
14 dossiers
View familyInsulin secretagogues stimulating pancreatic beta cells for diabetes.
6 dossiers
View familySedative-hypnotics modulating GABA or melatonin pathways for insomnia treatment.
9 dossiers
View familyCompounds classified in the Adaptogen family.
31 dossiers
View familyAngiotensin II receptor blockers for hypertension and diabetic nephropathy protection.
10 dossiers
View familyOrphan drug therapeutics addressing genetic and ultra-rare conditions with precision mechanisms.
37 dossiers
View familyMineralocorticoid receptor blockers for heart failure and hypertension.
31 dossiers
View familyPeptide therapeutics accelerating tissue remodeling, neural recalibration, and metabolic control.
10 dossiers
View familyHematopoietic stimulators driving blood cell production and recovery protocols.
33 dossiers
View familyCompounds classified in the Herbal family.
3 dossiers
View familyMuscarinic receptor blockers for COPD, overactive bladder, and motion sickness.
19 dossiers
View familyEicosanoid analogs for glaucoma, labor induction, and gastroprotection.
5 dossiers
View familyDHT blockers for benign prostatic hyperplasia and hair loss.
26 dossiers
View familyHistamine-2 receptor antagonists reducing gastric acid secretion.
22 dossiers
View familyCompounds classified in the Inhaled Steroid family.
35 dossiers
View familySkeletal muscle relaxants for acute musculoskeletal pain and spasm relief.
1 dossiers
View familyCompounds classified in the Antiseptic family.
7 dossiers
View familyGABA-A agonists for anesthesia, seizures, and insomnia (controlled substances).
12 dossiers
View familySodium-glucose cotransporter blockers for diabetes and heart failure.
3 dossiers
View familyCompounds classified in the Probiotic family.
4 dossiers
View familyAnabolic agents promoting bone formation for osteoporosis.
2 dossiers
View familyCompounds classified in the Opioid Treatment family.
3 dossiers
View familyCompounds classified in the Anxiolytic family.
1 dossiers
View familyCompounds classified in the Antipruritic family.
11 dossiers
View familyCompounds classified in the Mineral family.
29 dossiers
View familyCompounds classified in the Cannabinoid family.
2 dossiers
View familyCompounds classified in the PPAR Agonist family.
3 dossiers
View familyCompounds classified in the Protein family.
9 dossiers
View familySelective serotonin reuptake inhibitors for depression, anxiety, and mood disorder stabilization.
6 dossiers
View familyCompounds classified in the Mushroom family.
2 dossiers
View familyCompounds classified in the SSRI Antidepressant family.
1 dossiers
View familyCompounds classified in the Beta-2 Agonist family.
1 dossiers
View familyCompounds classified in the Fertility family.
1 dossiers
View familyCompounds classified in the Stool Softener family.
5 dossiers
View familyCompounds classified in the Racetam family.
1 dossiers
View familyCompounds classified in the Topical Steroid family.
5 dossiers
View familyPancreatic enzyme replacements for exocrine insufficiency and malabsorption syndromes.
5 dossiers
View familySerotonin-norepinephrine reuptake inhibitors for depression, anxiety, and neuropathic pain.
11 dossiers
View familyDipeptidyl peptidase-4 blockers enhancing incretin hormones for diabetes.
2 dossiers
View familyCompounds classified in the Cold Medicine family.
14 dossiers
View familyCompounds classified in the Dissociative family.
2 dossiers
View familyOsteoclast inhibitors for osteoporosis and bone metastases.
2 dossiers
View familyNext-gen incretin analogs tuned for aggressive weight normalization and glycemic stability.
2 dossiers
View familyCompounds classified in the SNRI Antidepressant family.
6 dossiers
View familyMonoclonal antibodies and fusion proteins targeting autoimmune, inflammatory, and immunological disorders.
3 dossiers
View familyPain-relieving compounds acting on peripheral and central pain pathways.
5 dossiers
View familyBronchodilators and anti-inflammatory agents for asthma, COPD, and respiratory distress management.
3 dossiers
View familyCompounds classified in the Depressant family.
1 dossiers
View familyCompounds classified in the Antiflatulent family.
2 dossiers
View familyCompounds classified in the Growth Hormone family.
2 dossiers
View familyCompounds classified in the Growth Hormone Secretagogue family.
2 dossiers
View familyCompounds classified in the Diabetes family.
2 dossiers
View familyIon channel correctors restoring chloride transport in cystic fibrosis pathology.
1 dossiers
View familyCompounds classified in the Dissociative/Antidepressant family.
2 dossiers
View familyCompounds classified in the Opioid-like family.
2 dossiers
View familyCompounds classified in the Mood Stabilizer family.
2 dossiers
View familyCompounds classified in the Fiber family.
3 dossiers
View familyAgents for overactive bladder, urinary incontinence, and urinary retention.
3 dossiers
View familyCompounds classified in the Antacid family.
2 dossiers
View familyNaloxone and naltrexone reversing opioid effects and treating addiction.
6 dossiers
View familyRapid-acting insulin secretagogues for postprandial glucose control.
1 dossiers
View familyCompounds classified in the Antidiarrheal family.
2 dossiers
View familyPPAR-gamma agonists improving insulin sensitivity in type 2 diabetes.
1 dossiers
View familyCompounds classified in the Hemorrhoid Treatment family.
1 dossiers
View familyCompounds classified in the Triple Agonist family.
1 dossiers
View familyCompounds classified in the Cough Suppressant family.
1 dossiers
View familyCompounds classified in the Hair Loss family.
1 dossiers
View familyCompounds classified in the GLP-1 Weight Loss family.
1 dossiers
View familyCompounds classified in the ED Medication family.
2 dossiers
View familyCompounds classified in the Rev-ErbA Agonist family.
1 dossiers
View familySynthetic levothyroxine and analogs for hypothyroidism replacement therapy.
1 dossiers
View familyCompounds classified in the GLP-1/GIP Agonist family.
1 dossiers
View familyCompounds classified in the Sleep/Antidepressant family.
1 dossiers
View familySmall molecule kinase inhibitors modulating inflammatory and autoimmune signaling cascades.
3 dossiers
View familyCompounds classified in the Thienodiazepine family.
9 dossiers
View familyCompounds classified in the Designer Benzodiazepine family.
7 dossiers
View familyBeta-keto amphetamine derivatives with stimulant and entactogenic effects.
10 dossiers
View familyCompounds classified in the Plant family.
6 dossiers
View familyAmphetamine-class compounds and derivatives acting on monoamine neurotransmitter systems.
6 dossiers
View familyCompounds classified in the Amphetamine family.
4 dossiers
View familyDissociative anesthetics blocking NMDA receptors for analgesia and anesthesia.
7 dossiers
View familyIndole alkaloids derived from tryptophan with serotonergic psychoactive properties.
1 dossiers
View familyCompounds classified in the Phenmetrazine family.
1 dossiers
View familyNitrogen-containing organic compounds of plant origin with diverse pharmacological activities.
1 dossiers
View familyCompounds classified in the Z-Drug family.
4 dossiers
View familyCompounds classified in the Inhalant family.
2 dossiers
View familyCompounds classified in the Acid family.
8 dossiers
View familyCompounds classified in the Solvent family.
1 dossiers
View familyCompounds classified in the Salt family.
1 dossiers
View familyCompounds classified in the Base family.
2 dossiers
View familyCompounds classified in the Reagent family.
1 dossiers
View familyCompounds classified in the Catalyst family.
2 dossiers
View familyCompounds classified in the Oxidizer family.
7 dossiers
View familyCompounds classified in the Precursor family.
4 dossiers
View familyCompounds classified in the Excipient family.
5 dossiers
View familyCompounds classified in the Gas family.
1 dossiers
View familyNeuromodulatory signals engineered for cognitive resilience and appetite governance.